NCT04378387 is a clinical trial in Primary Aldosteronism, sponsored by University of Turin, Italy.

Who is sponsoring NCT04378387?

NCT04378387 is sponsored by University of Turin, Italy.

Is NCT04378387 still recruiting?

NCT04378387 is currently completed. Last updated 7 May 2020.

Last reviewed 2020-05-07 · How we verify

NCT04378387

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism

Completed Last updated 7 May 2020

What this trial tests

trial in Primary Aldosteronism in 60 participants. Completed in 30 April 2020.

Timeline

1 January 2005

Primary endpoint
30 April 2020

30 April 2020

Quick facts

Lead sponsor	University of Turin, Italy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 January 2005
Primary completion	30 April 2020
Estimated completion	30 April 2020
Sites	1 location across Italy

Conditions studied

Primary Aldosteronism — all drugs for Primary Aldosteronism →
Primary Aldosteronism Due to Aldosterone Producing Adenoma — all drugs for Primary Aldosteronism Due to Aldosterone Producing Adenoma →
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) — all drugs for Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) →

Sponsor

University of Turin, Italy

Who can join

18 and older, any sex, with Primary Aldosteronism or Primary Aldosteronism Due to Aldosterone Producing Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adrenal vein sampling (AVS) is currently considered the gold standard for subtype diagnosis of primary aldosteronism (PA). However, the percentage of unsuitable procedures due to the unsuccessful cannulation of one of the two adrenal veins is still considerable, and there is no general consensus on the criteria that should be used for the interpretation of the results of an AVS study in these specific cases.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Accuracy of Simple and Adjusted Aldosterone Indices for Assessing Selectivity and Lateralization of Adrenal Vein Sampling in the Diagnosis of Primary Aldosteronism Subtypes.
Parasiliti-Caprino M, Bioletto F, Ceccato F, Lopez C, et al · · 2022 · cited 8× · PMID 35250861 · DOI 10.3389/fendo.2022.801529

Verify or expand the search:

Other recruiting trials for Primary Aldosteronism

Currently open trials in the same condition.

NCT07298954 — Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE) · NA · recruiting
NCT07111351 — Multi-omics Studies of Primary Aldosteronism · recruiting
NCT07027254 — PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism · NA · recruiting
NCT06941116 — Steroids-Based Screening for Primary Aldosteronism · recruiting
NCT06955286 — Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Witho · recruiting

Other University of Turin, Italy trials

Trials by the same sponsor.

NCT06493188 — Low VS High-fidelity Interprofessional Simulation for ABG Skills Acquisition · NA · not yet recruiting
NCT07418489 — Biotics Intervention Oriented to Rescue From Environmental Pollution Inflammatory Responses · NA · enrolling by invitation
NCT07311291 — The Effect of Different Hemostatic Agents on Hemorrhage Control, Pain and Quality of Life After Endodontic Microsurgery. · NA · completed
NCT06904963 — Efficacy of Oral Hygiene Instructions Carried Out Using an Intra-oral Scanner · NA · completed
NCT07047261 — Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04378387 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turin, Italy
Last refreshed: 7 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04378387.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing